Genetics, postprandial lipemia and obesity

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 11, Issue 2, 2001, Pages 118-133

  Ordovas, J M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Diet; Genetics; Genotype; Lipoproteins; Obesity; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN; LIPID;

ARTERIOSCLEROSIS; BLOOD; CORONARY ARTERY DISEASE; DIET; GENETIC PREDISPOSITION; GENETICS; HUMAN; OBESITY; POSTPRANDIAL STATE; REVIEW;

APOLIPOPROTEINS; ARTERIOSCLEROSIS; CORONARY DISEASE; DIET; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPIDS; OBESITY; POSTPRANDIAL PERIOD;

EID: 0035317433     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (180)

1. Zilversmit DB (1979) Atherosclerosis: A postprandrial phenomenon. Circulation 60: 473-485
2. Patsch JR, Miesenbock G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W (1992) Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345
3. Nikkilä M, Solakivi T, Lehtimäki T, Koivula T, Laippala P, Astrom B (1994) Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106: 149-157
4. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L (1991) Postprandial Lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662
5. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A (1996) Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years. Br Med J 312: 935-939
6. Denke MA, Adams-Huet B, Nguyen AT (2000) Individual cholesterol variation in response to a margarine-or butter-based diet. JAMA 284: 2740-2747
7. Cole TG, Bowen PE, Schmeisser D, Prewitt TE, Aye P, Langenberg P, Dolecek TA, Brace LD, Kamath S (1992) Differential reduction of plasma cholesterol by the American Heart Association Phase 3 Diet in moderately hypercholesterolemic, premenopausal women with different body mass indexes. Am J Clin Nutr 55: 385-394
8. Hannah JS, Jablonski KA, Howard BV (1997) The relationship between weight and response to cholesterol-lowering diets in women. Int J Obes 21: 445-450
9. Jansen S, Lopez-Miranda J, Salas J, Castro P, Paniagua JA, Lopez-Segura F, Ordovas JM, Jimenez-Pereperez JA, Blanco A, Perez-Jimenez F (1998) Plasma lipid response to hypolipidemic diets in young healthy non-obese men varies with body mass index. J Nutr 128: 1144-1149
10. Fielding CJ, Shore VG, Fielding PE (1972) A protein co-factor of lecithin:cholesterol acyltransferase. Biochem Biophys Res Commun 46: 1493-1498
11. Reichl D, Miller NE (1989) Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arterio 9: 785-797
12. Karathanasis SK (1985) Apolipoprotein multigene family: tandem organization of human apolipoprotein A-I, C-III and A-IV genes. Proc Natl Acad Sci USA 82: 6374-6378
13. Bruns GA, Karathanasis SK, Breslow JL (1984) Human apolipoprotein AI-CIII gene complex is located in chromosome 11. Arterio 4: 97-104
14. Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PW (1991) Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 87: 75-86
15. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE (1993) Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 100: 157-169
16. Paul-Hayase H, Rosseneu M, Van Bervliet JP, Deslypere JP, Humphries SE. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet (1992) 88: 439-446
17. Marshall HW, Morrison LC, Wu LL, Anderson JL, Cornell PS, Stauffer DM, Allen A, Karagounis LA, Ward RH (1994) Apolipoprotein polymorphisms fail to define risk of coronary artery disease: Results of a prospective, angiographically controlled study. Circulation 89: 567-577
18. Kee F, Amouyel P, Fumeron F, Arveiler D, Cambou JP, Evans A, Cambien F, Fruchart JC, Ducimetiere P, Dallongeville J (1999) Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis 145: 187-195
19. Karathanasis SK, Ferris E, Haddad IA (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84: 7198-7202
20. Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL, Schaefer EJ (1989) Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem 264: 16339-16342
21. Juo SHH, Wyszynski DF, Beaty TH, Huang HY, Bailey-Wilson JE (1999) Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and aplipoprotein A-I levels: A meta-analysis. Am J Med Genet 82: 235-241
22. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J, Perez-Jimenez F (1994) Influence of mutation in human apolipoprotein A-1 gene promot-er on plasma LDL cholesterol response to dietary fat. Lancet 343: 1246-1249
23. Mata P, Lopez-Miranda J, Pocovi M, Alonso R, Lahoz C, Marin C, Garces C, Cenarro A, Perez-Jimenez F, de Oya M, Ordovas JM (1998) Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 137: 367-376
24. Smith JD, Brinton EA, Breslow JL (1992) Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest 89: 1796-1800
25. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE (1992) Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett 304: 98-101
26. Wang XL, Badenhop RB, Sim AS, Wilcken DEL (1998) The effect of transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5′ untranslated region. Intern J Clin Lab Res 28: 235-241
27. Jeenah M, Kessling A, Miller N, Humphries SE (1990) G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 7: 233-241
28. Angotti E, Mele E, Costanzo F, Avvedimento EV (1994). A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269: 17371-17374
29. Danek GM, Valenti M, Baralle FE, Romano M (1998) The A/G polymorphism in the -78 position of the apolipoprotein A-I promoter does not have a direct effect on transcriptional efficiency. Biochim Biophys Acta 1398: 67-74
30. Green PH, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65: 911-919
31. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL (1990) Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J Biol Chem 265: 4266-4272
32. Steinmetz A, Utermann G (1985) Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem 260: 2258-2264
33. Fujimoto K, Machidori H, Iwakiri R, Yamamoto K, Fujisaki J, Sakata T, Tso P (1993) Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res 608: 233-237
34. Fujimoto K, Cardelli JA, Tso P (1992) Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 262: G1002-G1006
35. Fujimoto K, Fukagawa K, Sakata T, Tso P (1993) Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91: 1830-1833
36. Liu M, Shen L, Tso P (1999) The role of enterostatin and apolipoprotein AIV on the control of food intake. Neuropeptides 33: 425-433
37. Tso P, Liu M, Kalogeris TJ (2000) The role of apolipoprotein A-IV in food intake regulation. Journal of Nutrition 1503-1506
38. Stein O, Stein Y, Lefevre M, Roheim PS (1986) The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochi m Biophys Acta 878: 7-13
39. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G (1990) Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 265: 7859-7863
40. Weinberg RB, Patton CS (1990) Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim Biophys Acta 1044: 255-261
41. Kronenberg F, Stuhlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, Dieplinger H (2000) Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 36: 751-757
42. Fournier A, Atger V, Paul JL, Sturm M, Duverger N, Rothblat GH, Moatti N (2000) Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 20: 1283-1292
43. Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-Will S, Dieplinger H, Utermann G (1990) Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum Genet 84: 344-346
44. de Knijff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J, Havekes LM (1992) Lipoprotein profile of a Greenland Inuit population: Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb 12: 1371-1379
45. Von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H, Assmann G (1992) Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am J Hum Genet 50: 1115-1128
46. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF (1991) Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11: 1330-1348
47. Kamboh MI, Hamman RF, Iyengar S, Aston CE, Ferrell RE (1991) Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis 91: 25-34
48. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI (1989) Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 6: 493-499
49. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79: 368-372
50. Kamboh MI, Iyengar S, Aston CE, Hamman RF, Ferrell RE (1992) Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. Hum Biol 64: 605-616
51. Bai H, Saku K, Liu R, Funke H, Von Eckardstein A, Arakawa K (1993) Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. Biochim Biophys Acta 1174: 279-281
52. de Knijff P, Rosseneu M, Beisiegel U, De Keersgieter W, Frants RR, Havekes LM (1988) Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29: 1621-1627
53. Crews DE, Kamboh MI, Mancilha-Carvalho JJ, Kottke B (1993) Population genetics of apolipoprotein A-4, E, and H polymorphisms in Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism. Hum Biol 65: 211-224
54. Hanis CL, Douglas TC, Hewett-Emmett D (1991) Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum Genet 86: 323-325
55. Zaiou M, Visvikis S, Gueguen R, Parra H-J, Fruchart JC, Siest G (1994) DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clin Genet 46: 248-254
56. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ (1994) ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler Thromb 14: 884-891
57. McCombs RJ, Marcadis DE, Ellis J, Weinberg RB (1994) Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med 331: 706-710
58. Jansen S, Lopez-Miranda J, Ordovas JM, Zambrana JL, Marin C, Ostos MA, Castro P, McPherson R, Lopez Segura F, Blanco A, Jimenez Pereperez JA, Perez-Jimenez F (1997) Effect of 360His mutation in apolipoprotein A-IV on plasma HDL-cholesterol response to dietary fat. Journal of Lipid Research 38: 1995-2002
59. Heilbronn LK, Noakes M, Morris AM, Kind KL, Clifton P (2000) 360His polymorphism of the apolipoproteinA-IV gene and plasma lipid response to energy restricted diets in overweight subjects. Atherosclerosis 150: 187-192
60. Schuller E, Patel N, Item C, Greber-Platzer S, Baran H, Patsch W, Strobl W (2000) The genetic background modifies the effects of the obesity mutation, 'fatty', on apolipoprotein gene regulation in rat liver. Int J Obes 24: 460-467
61. Weinberg RB (1999) Apolipoprotein A-IV-2 allele: association of its worldwide distribution with adult persistence of lactase and speculation on its function and origin. Genet Epidemiol 17: 285-297
62. Jansen S, Lopez-Miranda J, Salas J, Ordovas JM, Castro P, Marin C, Ostos MA, Lopez-Segura F, Jimenez-Pereperez JA, Blanco A, Perez-Jimenez F (1997) Effect of 347-serine mutation in apoprotein A-IV on plasma LDL cholesterol response to dietary fat. Arterioscler Thromb Vasc Biol 17: 1532-1538
63. Rader DJ, Schafer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A, Brewer HB Jr (1993) Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the ApoA-IV-2 isoprotein. J Clin Invest 92: 1009-1017
64. Driscoll DM, Casanova E (1990) Characterization of the apolipoprotein B mRNA editing activity in enterocyte extracts. J Biol Chem 265: 21401-21403
65. Lau PP, Xiong W, Zhu H-J, Chen S-H, Chan L (1991) Apolipoprotein B mRNA editing is an intranuclear event that occurs post-transcriptionally coincident with splicing and polyadenylation. J Biol Chem 20550-20554
66. Law SW, Lackner KJ, Hospattankar AV, Anchors JM, Sakaguchi AY, Naylor SL, Brewer HB Jr (1985) Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc Natl Acad Sci USA 82: 8340-8344
67. Genest JJ Jr, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem DN, Wilson PW, Masharani U, Frossard PM, Schaefer EJ (1990) DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82: 7-17
68. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG, Miller GJ (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1: 1301-1302
69. Berg K (1986) DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin Genet 30: 515-520
70. Talmud PJ, Barni N, Kessling AM (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidemic individuals. Atherosclerosis 67: 81-89
71. Hixson JE, McMahan CA, McGill HC Jr, Strong JP, PDAY Research Group (1992) Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arterioscler Thromb 12: 1023-1029
72. Saha N, Tong MC, Tay JS, Jeyaseelan K, Humphries SE. DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients. Clin Genet (1992) 42: 164-170
73. Saha N, Tay JSH, Humphries SE (1992) Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI), serum lipids, and apolipoproteins in healthy Chinese. Genet Epidemiol 9: 1-10
74. Xu CF, Nanjee MN, Savill J, Talmud PJ, Angelico F, Del Ben M, Antonini R, Mazzarella B, Miller N, Humphries SE (1990) Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet 47: 429-439
75. Xu CF, Tikkanen MJ, Huttunen JK, Pietinen P, Butler R, Humphries S, Talmud P (1990) Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 31: 1255-1261
76. Carlsson P, Darnfors C, Olofsson SO, Bjursell G (1986) Analysis of the human apolipoprotein B gene: complete structure of the B74 region. Gene 49: 29-51
77. Aalto-Setälä K, Tikkanen M, Taskinen MR, Nieminen M, Homberg P, Kontula K (1988) XbaI and c/g polymorphism of the apolipoprotein B gene locus are associated with serum cholesterol and LDL cholesterol levels in Finland. Atherosclerosis 74: 47-54
78. Aalto-Setälä K, Viikari J, Åkerblom HK, Kuusela V, Kontula K (1991) DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood. J Lipid Res 32: 1477-1487
79. Hegele RA, Huang LS, Herbert PN (1986) Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 315: 1509-1515
80. Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT Greenhalgh RM, Humphries SE (1988) DNA polymorphism of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis 70: 123-129
81. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile DB, Humphries SE (1989) Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease. Atherosclerosis 71: 193-201
82. Tikkanen MJ, Xu C-F, Hamalainen T, Talmud P, Sarna S, Huttunen JK, Pietinen P, Humphries S (1990) XbaI Polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet 37: 327-334
83. Talmud PJ, Boerwinkle E, Xu C, Tikkanen MJ, Pietinen P, Huttunen JK, Humphries S (1992) Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet Epidemiol 9: 249-260
84. Lopez-Miranda J, Ordovas JM, Ostos MA, Marin C, Jansen S, Salas J, Blanco-Molina A, Jimenez-Pereperez JA, Lopez-Segura F, Perez-Jimenez F (1997) Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arterioscler Thromb Vasc Biol 17: 1765-1773
85. Turner PR, Talmud PJ, Visvikis S, Ehnholm C (1995) DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research Study. Atherosclerosis 116: 221-234
86. Boerwinkle E, Chan L (1989) A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B gene directly typed by the polymerase chain reaction. Nucleic Acids Res 17: 4003
87. Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G, Cambien F (1993) Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study". Hum Genet 90: 561-565
88. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P (1992) Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92: 151-164
89. Bohn M, Bakken A, Erikssen J, Berg K (1994) The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clin Genet 45: 255-259
90. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr, Patsch W (1991) Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 49: 1145-1154
91. Talmud P, Peacock R, Karpe F, Hamsten A, Humphries S (1996) ApoB genetic variants modulate postprandial lipoprotein metabolism. In: Pennington Biomedical Research Center (ed), Nutrition, Genetics and Heart Disease. LSU Press, Baton Rouge, pp. 366-378
92. Byrne CD, Wareham NJ, Mistry PK, Phillips DIW, Martensz ND, Halsall D, Talmud PJ, Humphries SE, Hales CN (1996) The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the postprandial state is altered by a common deletion polymorphism of the apoB signal peptide. Atherosclerosis 127: 35-42
93. Régis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G, Visvikis S (1995) Apo B signal peptide insertion deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 118: 23-34
94. Riches FM, Watts GF, Van Bockxmeer FM, Hua J, Song S, Humphries SE, Talmud PJ (1998) Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men. J Lipid Res 39: 1752-1758
95. Lopez-Miranda J, Jansen S, Ordovas JM, Salas J, Marin C, Castro P, Ostos MA, Cruz G, Lopez-Segura F, Blanco A, Jimenez-Pereperez J, Perez-Jimenez F (1997) Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat. Am J Clin Nutr 66: 97-103
96. Salas J, Jansen S, Lopez-Miranda J, Ordovas JM, Castro P, Marin C, Ostos MA, Bravo MD, Jimenez-Pereperez J, Blanco A, Lopez-Segura F, Perez-Jimenez F (1998) The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral glucose tolerance test after consumption of a diet rich in saturated fats. Am J Clin Nutr 68: 396-401
97. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS (2000) Interaction betwen obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein Lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 100: 327-333
98. Oppert JM, Fumeron F, Moreel JF, Apfelbaum M (1992) Association of a DNA polymorphism of the apolipoprotein A-I/C-III/A-IV gene cluster with hypertriglyceridemia in obese people. Int J Obes 16: 891-896
99. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37: 268-285
100. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ (1994) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 35: 1965-1975
101. Ordovas JM, Schaefer EJ (2000) Genetic determinants of plasma lipid response to dietary intervention: the role of the APOA1/C3/A4 gene cluster and the APOE gene. Br J Nutr 83: S127-S136
102. Dachet C, Poirier O, Cambien F, Rouis M (2000) New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vase Biol 20: 507-515
103. Dart AM, Cooper B (1999) Independent effects of apoE phenotype and plasma triglyceride on liporotein particle sizes in the fasting and postprandial states. Arterioscler Thromb Vasc Biol 19: 2465-2473
104. Boer JM, Ehnholm C, Menzel H-J, Havekes LM, Rosseneu M, O'Reilly DS, Tiret L (1997) Interactions between life-style related factors and the ApoE polymorphism on plasma lipids and apolipoproteins, The EARS Study. Arterioscler Thromb Vasc Biol 17: 1675-1681
105. Dart A, Sherrard B, Simpson H (1997) Influence of apoE phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis 130: 161-170
106. Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Connelly PW, Sing CF (2000) Impact of age and body size on inter-individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype. Clin Genet 57: 35-47
107. Yamashita S, Sakai N, Hirano K, Arai T, Ishigami M, Maruyama T, Matsuzawa Y (1997) Molecular genetics of plasma cholesteryl ester transfer protein. Curr Opin Lipidol 8: 101-110
108. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama Y, Mabuchi H, Tall AR (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323: 1234-1238
109. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, Miyamoto S, Moulin P, Tall AR, Mabuchi H (1991) Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis 90: 189-196
110. Takegoshi T, Haba T, Kitoh C, Inazu A, Koizumi J, Mabuchi H, Miyamoto S, Moulin P, Tall AR, Mabuchi H (1992) Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia. Atherosclerosis 96: 83-85
111. Inazu A, Jiang X-C, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y (1994) Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 94: 1872-1882
112. Hill SA, Nazir DJ, Jayaratne P, Bamford KS, McQueen MJ (1997) Mutations in cholesteryl ester transfer protein and hepatic lipase in a North American population. Clin Biochem 30: 413-418
113. Tamminen M, Kakko S, Kesäniemi YA, Savolainen MJ (1996) A polymorphic site in the 3′ untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis 124: 237-247
114. Drayna D, Lawn R (1987) Multiple RFLP's at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 15: 4698
115. Freeman D, Shepherd J, Packard CJ, Humphries SE, Gaffney D (1989) An Stul RFLP at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 17: 2880
116. Zuliani G, Hobbs HH (1990) EcoNI polymorphism in the human cholesteryl ester transfer protein (CETP) gene. Nucleic Acids Res 18: 2834
117. Kondo I, Berg K, Drayna DT, Lawn RM (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 35: 49-56
118. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ, Shepherd J (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14: 336-344
119. Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ (1994) Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110: 35-44
120. Kuivenhoven JA, de Knijff P, Boer JMA, Smalheer HA, Botma GJ, Seidell JC, Kastelein JJ, Pritchard PH (1997) Heterogeneity at the CETP gene locus - Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17: 560-568
121. Tenkanen H, Koskinen P, Kontula K, Aalto-Setälä K, Mänttäri M, Manninen V (1991) Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 87: 574-578
122. Mitchell RJ, Earl L, Williams J, Bisucci T, Gasiamis H (1994) Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol 66: 13-25
123. Fumeron F, Betoulle D, Luc G, Behague I, Ricard B, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96: 1664-1671
124. Kauma H, Savolainen MJ, Heikkilä R, Rantala AO, Lilja M, Reunanen A (1996) Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 97: 156-162
125. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338: 86-93
126. Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P (1988) Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260: 641-651
127. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20: 1323-1329
128. Dullaart RPF, Hoogenberg K, Riemens SC, Groener JEM, Van Tol A, Sluiter WJ, Stulp BK (1997) Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid lowering diet in type I diabetes. Diabetes 46: 2082-2087
129. Vohl MC, Lamarche B, Leroux G, Prud'homme D, Bouchard C, Nadeau A, Despres JP (1999) Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome. Int J Obes 23: 918-925
130. Cohen JC (1999) Contribution of cholesterol 7 alpha-hydroxylase to the regulation of lipoprotein metabolism. Curr Opin Lipidol 10: 303-307
131. De Fabiani E, Crestani M, Marrapodi M, Pinelli A, Golfieri V, Galli G (2000) Identification and characterization of cis-acting elements conferring insulin responsiveness on hamster cholesterol 7alpha-hydroxylase gene promoter. Biochem J 347: 147-154
132. Marrapodi M, Chiang JYL (2000) Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41: 514-520
133. Couture P, Otvos JD, Cupples LA, Wilson PWF, Schaefer EJ, Ordovas JM (1999) Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res 40: 1883-1889
134. Matarese V, Stone RL, Waggoner DW, Bernlohr DA (1989) Intracellular fatty acid trafficking and the role of cytosolic lipid binding proteins. Prog Lipid Res 28: 245-272
135. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett, PH, Bogardus C, Prochazka M (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287
136. Hegele RA (1998) A review of intestinal fatty acid binding protein gene variation and plasma lipoprotein response to dietary components. Clin Biochem 31: 609-612
137. Hegele RA, Wolever TM, Story A, Connelly PW, Jenkins DJ (1997) Intestinal fatty acid binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 27: 857-862
138. Baier LJ, Bogardus C, Sacchettini JC (1996) A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271: 10892-10896
139. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M (1998) Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vase Biol 18: 1606-1610
140. Bamberger M, Lund-Katz S, Phillips MC, Rothblat GH (1985) Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol
141. Johnson WJ, Bamberger MJ, Latta RA, Rapp PE, Phillips MC, Rothblat GH (1986) The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein. J Biol Chem 261: 5766-5776.
142. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW (1993) Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13: 720-728
143. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC (1997) A common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease participants. Arterioscler. Thromb Vase Biol 17: 2837-2842
144. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G Lindgren F, Gardiner G (1982) Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 45: 161-179
145. Barth JD, Jansen H, Hugenholtz PG, Birkenhager JC (1983) Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis. Atherosclerosis 48: 235-241
146. Barth JD, Jansen H, Kromhout D, Reiber JH, Birkenhager JC, Arntzenius AC (1987) Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis 68: 51-58
147. Dugi KA, Feuerstein IM, Hill S, Shih J, Santamarina-Fojo S, Brewer HB, Jr. Hoeg JM (1997) Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler Thromb Vase Biol 17: 354-364
148. Couture P, Otvos JD, Cupples LA, Wilson PWF, Schaefer EJ, Ordovas JM (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20: 815-828
149. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC (1998) Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 39: 1127-1130
150. Warden CH, Fisler JS, Shoemaker SM, Wen P-Z, Svenson KL, Pace MJ, Lusis AJ (1995) Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest 95: 1545-1552
151. Goldberg IJ (1996) Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolismand atherogenesis. J Lipid Res 37: 693-707
152. Beisiegel U, Weber W, Bengtsson-Olivecrona G (1991) Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 88: 8342-8346
153. Patsch JR, Prasad S, Gotto AM, Jr., Patsch W (1987) High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80: 341-347
154. Enerbäck S, Gimble JM (1993) Lipoprotein lipase gene expression: Physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1169: 107-125
155. Deeb SS, Peng RL (1989) Structure of the human lipoprotein lipase gene. Biochemistry 28: 4131-4135
156. Kirchgessner TG, Chuat GC, Heinzmann C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon C, d'Auriol L, Andalibi A (1989) Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc Natl Acad Sci USA 86: 9647-9651
157. Oka K, Tkalcevic GT, Wakano T, Tucker H, Ishimura-Oka K, Brown WV (1990) Structure and polymorphic map of human lipoprotein lipase. Biochim Biophys Acta 1049: 21-26
158. Chuat J-C, Raisonnier A, Etienne J, Galibert F (1992) The lipoprotein lipase-encoding human gene: Sequence from intron-6 to intron-9 and presence in intron-7 of a 40-million-year-old Alu sequence. Gene 110: 257-261
159. Fisher L, FitzGerald GA, Lawn RM (1987) Two polymorphisms in the human lipoprotein lipase gene. Nucleic Acids Res 15: 7675
160. Heinzmann C, Ladias JA, Antonarakis SE, Kirchgessner T, Schotz MC, Lusis AJ (1987) RFLP for human lipoprotein lipase gene; HindIII. Nucl Acids Res 15: 6763
161. Zhang HF, Henderson H, Gagne SE, Clee SM, Miao L, Liu GQ (1996) Common sequence variants of lipoprotein lipase: Standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302: 159-166
162. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ (1998) Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fast-ing and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18: 526-534
163. Proenza AM, Poissonnet CM, Ozata M, Ozen S, Guran S, Palou A, Strosberg AD (2000) Associations of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling probein 1 and lipoprotein lipase with increased risk of metabolic complications of obesity. Int J Obes 24: 93-100
164. Zhang Q, Cavallero E, Hoffmann MM, Cavanna J, Kay A, Charles A, Braschi S, Marz W, Perlemuter L, Jacotot B, Galton DJ (1997) Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia. Clin Sci 93: 335-341
165. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F (1995) Lipoprotein lipase gene polymorphisms: Associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 19: 270-274
166. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE (1995) Interaction of the lipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: A study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 36: 2104-2112
167. Vohl M-C, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C Lupien PJ, Despres JP (1995) The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb 15: 714-720
168. Jemaa R, Tuzet S, Betoulle D, Apfelbaum M, Fumeron F (1997) Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int J Obes 21: 280-283
169. Sentí M, Bosch M, Aubo C, Elosua R, Masia R, Marrugat J (2000) Relationship of abdominal adiposity and dyslipidemic status in women with a common mutation in the lipoprotein lipase gene. The REGICOR Investigators. Atherosclerosis 150: 135-141
170. Kern PA (1997) Potential role of TNFalpha and lipoprotein lipase as candidate genes for obesity. J Nutr 127: 1917S-1922S
171. Acton S, Rigotti A, Landschulz KT, Xu SZ, Hobbs HH, Krieger M (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-520
172. Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Quehenberger O (1997) Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 272: 17551-17557
173. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH (1997) Structure and localization of the human gene encoding SR-BI/CLA-1: evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272: 33068-33076
174. Rigotti A, Trigattt B, Babitt J, Penman M, Xu S, Krieger M (1997) Scavenger receptor BI: a cell surface receptor for high density lipoprotein. Curr Opin Lipidol 8: 181-188
175. Calvo D, Vega MA (1993) Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 268: 18929-18935
176. Acton SL, Scherer PE, Lodish HF, Krieger M (1994) Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 269: 21003-21009
177. Glass C, Pittman RC, Weinstein DB, Steinberg D (1983) Dissociation of tissue uptake of cholesterol ester from that of apoproteinA-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci USA 80: 5435-5439.
178. Calvo D, Gomez-Coronado D, Lasunción MA, Vega MA (1997) CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler Thromb Vase Biol 17: 2341-2349
179. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A Mozas P, Keilty J, Squazzo S, Woolf EA, Ordovas JM (1999) Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19: 1734-1743
180. Hauser H, Dyer JH, Nandy A, Vega MA, Werder M, Bieliauskaite E Weber FE, Compassi S, Gemperli A, Boffelli D, Wehrli E, Schulthess G, Phillips MC (1998) Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 37: 17843-17850